Wall Street analysts predict that Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) will announce sales of $26.19 million for the current quarter, according to Zacks. Four analysts have made estimates for Novadaq Technologies’ earnings, with estimates ranging from $25.30 million to $27.00 million. Novadaq Technologies reported sales of $22.16 million during the same quarter last year, which would suggest a positive year over year growth rate of 18.2%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, November 1st.

According to Zacks, analysts expect that Novadaq Technologies will report full year sales of $26.19 million for the current fiscal year, with estimates ranging from $94.62 million to $99.80 million. For the next year, analysts forecast that the company will report sales of $123.86 million per share, with estimates ranging from $119.00 million to $127.70 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow Novadaq Technologies.

Several research firms recently issued reports on NVDQ. BidaskClub raised shares of Novadaq Technologies from a “strong sell” rating to a “sell” rating in a research report on Tuesday, August 22nd. Zacks Investment Research raised shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Northland Securities reissued a “hold” rating and issued a $11.75 target price on shares of Novadaq Technologies in a research report on Monday, August 14th. JMP Securities reissued a “market perform” rating on shares of Novadaq Technologies in a research report on Thursday, July 13th. Finally, Royal Bank Of Canada cut shares of Novadaq Technologies from an “outperform” rating to a “sector perform” rating and decreased their target price for the stock from $12.00 to $11.75 in a research report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $11.86.

TRADEMARK VIOLATION WARNING: “$26.19 Million in Sales Expected for Novadaq Technologies Inc (NVDQ) This Quarter” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/31/26-19-million-in-sales-expected-for-novadaq-technologies-inc-nvdq-this-quarter.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Gamco Investors INC. ET AL acquired a new position in shares of Novadaq Technologies during the second quarter worth $145,000. Virtu Financial LLC acquired a new position in shares of Novadaq Technologies during the second quarter worth $157,000. Envestnet Asset Management Inc. boosted its position in shares of Novadaq Technologies by 12.9% in the first quarter. Envestnet Asset Management Inc. now owns 25,374 shares of the medical research company’s stock worth $197,000 after buying an additional 2,898 shares during the period. Wolverine Trading LLC acquired a new position in shares of Novadaq Technologies during the second quarter worth $254,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in shares of Novadaq Technologies during the second quarter worth $255,000. 75.38% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Novadaq Technologies (NASDAQ:NVDQ) remained flat at $11.75 during trading on Monday. The company had a trading volume of 395,280 shares. Novadaq Technologies has a 52 week low of $5.84 and a 52 week high of $12.74. The company’s market cap is $679.41 million. The firm’s 50-day moving average price is $11.68 and its 200 day moving average price is $8.94.

Novadaq Technologies Company Profile

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Get a free copy of the Zacks research report on Novadaq Technologies (NVDQ)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Stock Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related stocks with our FREE daily email newsletter.